Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
56M
-
Shares change
-
-1.57M
-
Total reported value, excl. options
-
$408M
-
Value change
-
-$10.3M
-
Put/Call ratio
-
1.27
-
Number of buys
-
50
-
Number of sells
-
-49
-
Price
-
$7.28
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q3 2025
129 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q3 2025.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56M shares
of 56.3M outstanding shares and own 99.46% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.49M shares), FMR LLC (5.15M shares), Vestal Point Capital, LP (4.96M shares), FCPM III SERVICES B.V. (4.11M shares), Fairmount Funds Management LLC (3.55M shares), BlackRock, Inc. (3.49M shares), MILLENNIUM MANAGEMENT LLC (3.03M shares), TCG Crossover Management, LLC (2.76M shares), VANGUARD GROUP INC (2.64M shares), and VR ADVISER, LLC (2.46M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.